Skip to main content
SpringerLink
Log in

Behavioral Pharmacology of Opiates

  • Chapter
Handbook of Substance Abuse

  • 282 Accesses

Abstract

The purpose of this chapter is to describe and discuss what is currently known about the behavioral pharmacology of opioids in infra-humans and humans. This is a daunting task, given the breadth and depth of research that has been conducted during the past 50 years. Several reviews on the behavioral pharmacology of opioids cover certain areas in much greater detail than what can be covered here; the reader is encouraged to refer to these reviews, some of which appear yearly as an “update” (see Appendix for review bibliography).*

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aigner, B., and Balster, R. L. (1979). Rapid substitution procedure for iv drug self-administration studies in rhesus monkeys. Pharmacology, Biochemistry and Behavior; 10, 105–112.

    CAS  Google Scholar 

  • Almaric, M., Cline, E., Martinez, J., Jr., Bloom, F. E., and Koob, G. (1987). Rewarding properties of beta-endorphin as measured by conditioned place preference. Psychopharmacology, 91, 14–19.

    Google Scholar 

  • Angle, H. V, Knowles, R. R., Marrazzi, A. S., and Sletten, I. W. (1973). Method for self-administering methadone by the heroin addict. International Journal of the Addictions. 8. 435–441.

    PubMed  CAS  Google Scholar 

  • Bals-Kubik, R., Herz, A., and Shippenberg, T. (1989). Evidence that the aversive effects of opioid antagonists and k-agonists are centrally mediated. Psvchopharmacologv, 98, 203–206.

    CAS  Google Scholar 

  • Bals-Kubik, R., Shippenberg, T. S., and Herz, A. (1990a). Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. European Journal of Pharmacology, 175, 63–69.

    PubMed  CAS  Google Scholar 

  • Bals-Kubik, R., Shippenberg, T. S., and Herz, A. (1990b). Neuroanatomical substrates mediating the motivational effects of opioids. In J. van Ree, A. Mulder, V. Wiegart, and T. van Wimersma-Geidarus (Eds.), New Leads in Opioid Research. Proceedings of the International Narcotics Research Conference (pp. 11–12 ). Amsterdam: Exerpta Medica.

    Google Scholar 

  • Balster, R. L. (1989). Substitution and antagonism in rats trained to discriminate (+)-n-allylnormetazocine from saline. Journal of Pharmacology and Experimental Therapeutics, 249, 749–756.

    PubMed  CAS  Google Scholar 

  • Balster, R. L., and Lukas, S. E. (1985). Review of self-administration. Drug and Alcohol Dependence, 14, 249–261.

    PubMed  CAS  Google Scholar 

  • Bechara, S., and van der Kooy, D. (1987). Kappa receptors mediate the peripheral aversive effects of opiates. Pharmacology, Biochemistry and Behavior, 28, 227–233.

    CAS  Google Scholar 

  • Bellville, J. W, and Green, J. (1965). The respiratory and subjective effects of pentazocine. Clinical Pharmacology and Therapeutics, 6, 152–159.

    PubMed  CAS  Google Scholar 

  • Bergman, J., and Carey, G. (1996). Antagonism of the discriminative stimulus effects of enadoline. In L. S. Harris (Ed.), Problems of drug dependence 1996 (NIDA Research Monograph No. 174, p. 312 ). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Berman, M. L., Briggs, G. G., Bogh, P., Mannel, R., Manetta, A., and DiSaia, P. J. (1990). Simplified postoperative patient-controlled analgesia on a gynecology-oncology service. Gynecologic Oncology, 38, 55–58.

    CAS  Google Scholar 

  • Bertalmio, A. J., and Woods, J. H. (1987). Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: Apparent pA2 analysis. Journal of Pharmacology and Experimental Therapeutics, 243, 591–597.

    PubMed  CAS  Google Scholar 

  • Bertalmio, A. J., and Woods, J. H. (1989). Reinforcing effect of alfentanil is mediated by mu opioid receptors: Apparent pA, analysis. Journal of Pharmacology and Experimental Therapeutics, 251, 455–460.

    Google Scholar 

  • Bertalmio, A. J., Herling, S., Hampton, R., Winger, G., and Woods, J. H. (1982). A procedure for rapid evaluation of the discriminative stimulus effects of drugs. Journal of Pharmacological Methods, 7, 289–299.

    PubMed  CAS  Google Scholar 

  • Bickel, W. K., Higgins, S. T., and Stitzer. M. L. (1986). Choice of blind methadone dose increases by methadone maintenance patients. Drug and Alcohol Dependence, 18, 165–171.

    PubMed  CAS  Google Scholar 

  • Bigelow, G. E., and Preston, K. L. (1995). Opioids. In F. E. Bloom and D. J. Kupfer (Eds.), Psychopharnracologv: The fourth generation of progress (pp. 1731–1744 ). New York: Raven.

    Google Scholar 

  • Boccuni, M., Cangi, F., Fusco, B. M., Curradi, C., and Sicuteri, F. (1987). Pentazocine in migraine: Subjective and pupillary abnormal effects. Headache, 27, 503–508.

    PubMed  CAS  Google Scholar 

  • Butelman, E. R., Winger, G., Zernig, G., and Woods. J. H. (1995). Butorphanol: Characterization of agonist and antagonist effects in rhesus monkey. Journal of Pharmacology and Experimental Therapeutics, 272, 845–853.

    Google Scholar 

  • Carr, G., Fibiger, H., and Phillips, A. (1989). Conditioned place preference as a measure of drug reward. In J. Liebman and S. Cooper (Eds.). The neuropharmacological basis of reward (pp. 264–319 ). New York: Oxford University Press.

    Google Scholar 

  • Carroll, M. E., and Meisch, R. A. (1978). Etonitazene as a reinforcer: Oral intake of etonitazene by rhesus monkeys. Psychopharmacologv, 59, 225–229.

    CAS  Google Scholar 

  • Chappell, P. B., Leckman, J. F., Scahill, L. D., Hardin, M. T., Anderson, G., and Cohen, D. J. (1993). Neuroendocrine and behavioral effects of the selective rc agonist spiradoline in Tourette’s syndrome: A pilot study. Psychiatry Research, 47, 267–280.

    PubMed  CAS  Google Scholar 

  • Collins, R., Weeks, J., Cooper, M., Good, R. and Russell, R. (1984). Prediction of abuse liability of drugs using IV self-administration by rats. Psvchopharmacologv, 82, 6–13.

    CAS  Google Scholar 

  • Colpaert, F. C. (1977). Drug-produced cues and states: Some theoretical and methodological inferences. In H. Lal (Ed.), Discriminative stimulus properties of drugs (pp. 5–21 ). New York: Amsterdam.

    Google Scholar 

  • Colpaert, F. C., Niemegeers, C., and Janssen. P. A. (1980). Factors regulating drug cue sensitivity: The effect of training dose in fentanyl-saline discrimination. Neuropharmacology, 19, 705–713.

    Google Scholar 

  • Colpaert, F. C., Meert, T., De Witte, P. and Schmitt. P. (1982). Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sciences, 31, 67–75.

    PubMed  CAS  Google Scholar 

  • Comer, S. D., McNutt, R., Chang, K., DeCosta, B. R., Mosberg, H., and Woods, J. H. (1993). Discriminative stimulus effects of BW373U86: A nonpeptide ligand with selectivity for delta opioid receptors. Journal of Pharmacology and Experimental Therapeutics, 267, 866–874.

    PubMed  CAS  Google Scholar 

  • Devine, D. P, and Wise, R. A. (1994). Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of the rat. Journal of Neuroscience, 14, 1978–1984.

    PubMed  CAS  Google Scholar 

  • Downs, D. A., and Woods, J. H. (1975). Fixed-ratio escape and avoidance-escape from naloxone in morphine-dependent monkeys: Effects of naloxone dose andn morphine pretreatment. Journal of Experimental Analysis of Behavior; 23. 415–427.

    Google Scholar 

  • Downs, D. A., and Woods, J. H. (1976). Naloxone as a negative reinforcer in rhesus monkeys: Effects of dose, schedule, and narcotic regimen. Pharmacological Reviews, 27, 397–406.

    Google Scholar 

  • Dykstra, L. D., Gmerek, D. E., Winger, G., and Woods, J. H. (1987). Kappa opioids in rhesus monkeys: II. Analysis of the antagonistic actions of quadazocine and Bfunaltrexamine. Journal of Pharmacology and Experimental Therapeutics, 242, 421–427.

    PubMed  CAS  Google Scholar 

  • Emmett-Olgesby, M., Shippenberg, T., and Herz, A. (1988). Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine. Journal of Pharmacology and Experimental Therapeutics, 245, 17–23.

    Google Scholar 

  • France. C. P., and Woods, J. H. (1985). Opiate agonist-antagonist interactions: Application of a three-key drug discrimination procedure. Journal of Pharmacology and Experimental Therapeutics, 234, 81–89.

    Google Scholar 

  • France, C. P., and Woods, J. H. (1987). (3-Funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons. Psychopharnracologm, 9/, 213–216.

    Google Scholar 

  • France. C. P., and Woods, J. H. (1990). Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. Journal of Pharmacology and Experimental Therapeutics, 254, 626–632.

    PubMed  CAS  Google Scholar 

  • France, C. P., de Costa, B. R., Jacobson, A. E., Rice, K. C., and Woods, J. H. (1990). Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. Journal of Pharmacology and Experimental Therapeutics, 252, 600–604.

    PubMed  CAS  Google Scholar 

  • France, C. P., Medzihradsky, F., and Woods, J. H. (1994). Comparison of kappa opioids in rhesus monkeys: Behavioral effects and receptor binding affinities. Journal of Pharmacology and Experimental Therapeutics. 268, 47–58.

    PubMed  CAS  Google Scholar 

  • Fraser, H. F., and Rosenberg, D. E. (1964). Studies on the human addiction liability of 2’-hydroxy-5.9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan (WIN 20,228): A weak narcotic antagonist. Journal of Pharmacology and Experimental Therapeutics, 143, 149–156.

    Google Scholar 

  • Fraser. H. F., Martin, W. R., Wolbach, A. B., and Isbell, H. (1961). Addiction liability of an isoquinoline analgesic, 1-(p-chlorophenetyl)-2-methyl-6,7-dimethoxy-1,2,3,4tetrahydrois oquinoline. Clinical Pharmacology and Therapeutics, 2, 287–299.

    PubMed  CAS  Google Scholar 

  • Fraser, H. F., van Horn, G. G., Martin, W. R., Wolbach, A. B., and Isbell, H. (1961). Methods for evaluating abuse liability. (A) “Attitude” of opiate addicts towards opiate-like drugs. (B) A short-term “direct” addiction test. Journal of Pharmacology and Experimental Therapeutics, 133, 371–387.

    PubMed  CAS  Google Scholar 

  • Gauvin, D., and Young, A. M. (1989). Effects of prior saline-morphine discrimination by pigeons on three-way discrimination including two morphine doses. Psychopharmacology 98, 222–230.

    PubMed  CAS  Google Scholar 

  • Gerak, L. R., and France, C. P. (1996). Discriminative stimulus effects of nalbuphine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 276, 523–531.

    PubMed  CAS  Google Scholar 

  • Glick, S. D., Maisonneve, I. M., Raucci, J., and Archer, S. (1995). Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Research, 681, 147–152.

    PubMed  CAS  Google Scholar 

  • Gorodetzky, C. W., and Martin, W. R. (1966). A comparison of fentanyl, droperidol, and morphine. Clinical Pharmacology and Therapeutics, 6, 731–739.

    Google Scholar 

  • Graves, D. A., Arrigo, J. M., Foster, T. S., Baumann, T. J., and Batenhorst, R. L. (1985). Relationship between plasma morphine concentrations and pharmacologic effects in postoperative patients using patient-controlled analgesia. Clinical Pharmacy, 4. 41–47.

    PubMed  CAS  Google Scholar 

  • Greenwald, M. K., June, H. L., Stitzer, M. L., and Marco, A. P. (1996). Comparative pharmacology of short-acting mu opioids in drug abusers. Journal of Pharmacology and Experimental Therapeutics, 277, 1228–1236.

    PubMed  CAS  Google Scholar 

  • Haertzen, C. A. (1966). Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychological Reports, 18, 163–194.

    PubMed  CAS  Google Scholar 

  • Haertzen, C. A. (1970). Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory ( ARCI ). Psychopharrnacologia, 18, 366–377.

    Google Scholar 

  • Hamilton, R. C., Dundee, J. W., Clarke, S. J., Loan, W. B., and Morrison, J. D. (1967). Studies of drugs given before anaesthesia: XIII. Pentazocine and other opiate antagonists. British Journal of Anaesthesia, 39, 647–656.

    PubMed  CAS  Google Scholar 

  • Hein, D. W., Young, A. M., Herling, S., and Woods, J. H. (1981). Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. Journal of Pharmacology and Experimental Therapeutics, 218, 7–15.

    PubMed  CAS  Google Scholar 

  • Herling, S., Coale, E., Jr., Valentino, R. J.. Hein, D. W., and Woods, J. H. (1980). Narcotic discrimination in pigeons. Journal of Pharmacology and Experimental Therapeutics, 214, 139–146.

    CAS  Google Scholar 

  • Hoffman, D. (1989). The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Research Bulletin, 23, 373–387.

    PubMed  CAS  Google Scholar 

  • Hoffmeister, F. (1979). Progressive-ratio performance in the rhesus monkey maintained by opiate infusions. Psychopharmacology, 62, 181–186.

    PubMed  CAS  Google Scholar 

  • Holtzman, S. G. (1982). Discriminative stimulus properties of opioids in the rat and squirrel monkey. In F. C. Colpaert and J. Slangen (Eds.), Drug discrimination: Applications in CNS pharmacology (pp. 17–36 ). Amsterdam: Elsevier Biomedical Press.

    Google Scholar 

  • Holtzman, S. G. (1983). Discriminative stimulus properties of opioid agonists and antagonists. In S. Cooper (Ed.), Theory in psvchopharmacologv (Vol. 2, pp. 1–45 ). London: Academic Press.

    Google Scholar 

  • Holtzman, S. (1985). Discriminative stimulus effects of morphine withdrawal in the morphine-dependent rat: Suppression by opiate and nonopiate drugs. Journal of Pharmacology and Experimental Therapeutics, 233, 80–86.

    PubMed  CAS  Google Scholar 

  • Holtzman, S. G., and Locke, K. W. (1988). Neural mechanisms of drug stimuli: Experimental approaches. Transduction mechanisms of drug stimuli. In F. Colpaert and R. Balster (Eds.), Psychopharmacology (pp. 139–153 ). Berlin: Springer-Verlag.

    Google Scholar 

  • Holtzman, S. G., and Steinfels, G. F. (1994). Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline. Psychopharmacology, 116, 243–248.

    PubMed  CAS  Google Scholar 

  • Holtzman, S. G., Cook, L., and Steinfels, G. F. (1991). Discriminative stimulus effects of spiradoline, a kappaopioid agonist. Psychopharmacology, 105. 447–452.

    PubMed  CAS  Google Scholar 

  • larbe, T. (1978). Discriminative effects of morphine in the pigeon. Pharmacology, Biochemistry and Behavior 9, 411–416.

    Google Scholar 

  • Jasinski, D. R., and Mansky, P. A. (1972). Evaluation of nalbuphine for abuse potential. Clinical Pharmacology and Therapeutics, 13, 78–90.

    PubMed  CAS  Google Scholar 

  • Jasinski, D. R. and Preston, K. L. (1985). Assessment of dezocine for morphine-like subjective effects and miosis. Clinical Pharmacology and Therapeutics 38544–548.

    Google Scholar 

  • Jasinski, D. R., and Preston, K. L. (1986). Evaluation oftilidine for morphine-like subjective effects and euphoria. Drug and Alcohol Dependence, 18, 273–292.

    PubMed  CAS  Google Scholar 

  • Jasinski, D. R., Martin, W. R., and Sapira, J. D. (1968). Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone. Clinical Pharnracologv and Therapeutics, 9. 215–222.

    CAS  Google Scholar 

  • Jasinski, D. R., Martin, W. R., and Haeldke, R. D. (1970). Effects of short-and long-term administration of pentazocine in man. Clinical Pharmacology and Therapeutics 11385–403.

    Google Scholar 

  • Jewett, D. C.. Mosberg, H.. and Woods, J. H. (1996). Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin in pigeons. Psychopharmacology, 127, 225–229.

    Google Scholar 

  • Jones, B. E., and Prada, J. A. (1975). Drug-seeking behavior during methadone maintenance. Psychopharmacologia (Berlin), 41, 7–10.

    CAS  Google Scholar 

  • Kitchen, 1., and Kennedy, A. (1990). Effects of 8-opioid receptor antagonist naltrindole on opioid induced in vivo release of corticosterone. In J. van Ree, A. Mulder, V. Wiegant, and T. van Wimersma Griedanus (Eds.), New leads in opioid research (pp. 2321–2322 ). Amsterdam: Excerpta Medica.

    Google Scholar 

  • Koek, W., and Woods, J. H. (1989). Partial generalization in pigeons trained to discriminate morphine from saline: Applications of receptor theory. Drug Development Research, 16, 169–181.

    Google Scholar 

  • Koob, G. F. (1992). Neural mechanisms of drug reinforcement. Annals of the New York Academy of Sciences, 654, 171–191.

    PubMed  CAS  Google Scholar 

  • Kumor, K. M., Haertzen, C. A., Johnson, R. E., Kocher, T., and Jasinski, D. R. (1986). Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. Journal of Pharmacology and Experimental Therapeutics, 238, 960–968.

    PubMed  CAS  Google Scholar 

  • Kupers, R., and Gybels, J. (1995). The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain. Pain, 60. 137–141.

    PubMed  CAS  Google Scholar 

  • Lamb, R. J., Preston, K. L., Schindler, C. W., Meisch, R. A., Davis, F., Katz. J. L., Henningfield, J. E., and Goldberg, S. R. (1991). The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. Journal of Pharmacology and Experimental Therapeutics, 259, 1 165–1 173.

    Google Scholar 

  • Lasagna, L., von Felsinger, J. M., and Beecher, J. K. (1955). Drug-induced mood changes in man. Journal of the American Medical Association, 157, 1006–1020.

    PubMed  CAS  Google Scholar 

  • Locke, K. W., and Holtzman, S. G. (1985). Characterization of the discriminative stimulus effects of centrally-administered morphine in the rat. Psychopharmacology, 87, 1–6.

    PubMed  CAS  Google Scholar 

  • Locke, K. W., and Holtzman, S. G. (1986). Behavioral effects of opioid peptides selective for mu or delta receptors: I. Morphine-like discriminative stimulus effects. Journal of Pharmacology and Experimental Therapeutics, 238, 900–906.

    Google Scholar 

  • Lord, J. A. H., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W. (1977). Endogenous opioid peptides: Multiple agonists and receptors. Nature, 267, 495–499.

    PubMed  CAS  Google Scholar 

  • Lukas, S. E., Griffiths, R. R., and Brady, J. V. (1983). Buprenorphine self-administration by the baboon: Comparison with other opioids. In L. S. Harris (Ed.), Problems of drug dependence 1982 (NIDA Monograph Series No. 43, pp. 178–183 ). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Lukas, S. E., Brady, J. V., and Griffiths, R. R. (1986). Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon. Journal of Pharmacology and Experimental Therapeutics, 238, 924–931.

    PubMed  CAS  Google Scholar 

  • Martin, T. J., Dworkin, S. I., and Smith. J. E. (1995). Alkylation of mu opioid receptors by (3-funaltrexamine in vivo: Comparison of the effects on in situ binding and heroin self-administration in rats. Journal of Pharmacology and Experimental Therapeutics. 272, 1135–1140.

    PubMed  CAS  Google Scholar 

  • Martin, W R., and Fraser, H. F. (1961). A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. Journal of Pharmacology and Experimental Therapeutics, 133, 388–399.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., Sloan, J. W., Sapira, J. D., and Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245–258.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E.. and Gilbert, P. E. (1976) The effects of mor-phine-and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. Journal of Pharmacology and Experimental Therapeutics. 197, 517–532.

    PubMed  CAS  Google Scholar 

  • Meisch, R. A. (1995). Oral self-administration of etonitazene in rhesus monkeys: Use of a fading procedure to establish etonitazene as a reinforcer. Pharmacology, Biochemistry and Behavior, 50, 571–580.

    CAS  Google Scholar 

  • Mello, N. K., Bree, M., and Mendelson, J. (1981). Buprenorphine self-administration by rhesus monkeys. Pharmacology, Biochemistry and Behavior, 15, 215–225.

    Google Scholar 

  • Mello, N. K.. Mendelson, J. H., Kuehnle, J. C., and Sellers, M. S. (1981). Operant analysis of human heroin self-administration and the effects of naltrexone. Journal of Pharmacology and Experimental Therapeutics, 216, 45–54.

    PubMed  CAS  Google Scholar 

  • Mello, N. K., Mendelson, J. H., and Kuehnle, J. C. (1982). Buprenorphine effects on human heroin self-administration: an operant analysis. Journal of Pharmacology and Experimental Therapeutics, 223, 30–39.

    PubMed  CAS  Google Scholar 

  • Mello, N. K.. Bree, M., and Mendelson, J. (1983). Comparison of buprenorphine and methadone effects on opiate self-administration. Journal of Pharmacology and Experimental Therapeutics, 225, 378–386.

    CAS  Google Scholar 

  • Mello, N. K., Mendelson, J., Bree, M., and Lukas, S. E. (1989). Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science, 245, 859–862.

    PubMed  CAS  Google Scholar 

  • Mello, N. K.. Lukas. S. E., Kamien, J. B., Mendelson, J. H., Drieze, J., and Cone, E. J. (1992). The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. Journal of Pharmacology’ and Experimental Therapeutics, 260, 1185–1193.

    PubMed  CAS  Google Scholar 

  • Miksic, L., and LaI, H. (1977). Tolerance to morphine-produced discriminative stimuli and analgesia. Psychopharmacology. 54, 217–211.

    PubMed  CAS  Google Scholar 

  • Mucha, R., and Herz, A. (1985). Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacologv, 86. 274–280.

    CAS  Google Scholar 

  • Negus, S. S., Burke, T. F., Medzihradsky, F., and Woods, J. H. (1993). Effects of opioid agonists selective for mu, kappa, and delta opioid receptors on schedule-controlled responding in rhesus monkeys: Antagonism by quadazocine. Journal of Pharmacology and Experimental Therapeutics. 267, 896–902.

    PubMed  CAS  Google Scholar 

  • Negus, S. S., Butelman, E. R., Chang, K., DeCosta, B., Winger, G., and Woods, J. H. (1994). Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 270, 1025–1034.

    PubMed  CAS  Google Scholar 

  • Negus, S. S., Mello, N. K., Portoghese, P. S., Lukas, S. E., and Mendelson, J. H. (1995). Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 273, 1245–1256.

    PubMed  CAS  Google Scholar 

  • Pande, A. C., Pyke, R. E., Greiner, M., Wideman, G. L., Benjamin, R., and Pierce, M. W. (1996). Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain. Clinical Neuropharnracologv, 19, 451–456.

    CAS  Google Scholar 

  • Parker, R. K., Holtmann, B., and White, P. F. (1991). Patient-controlled analgesia: Does a concurrent opioid infusion improve pain management after surgery? Journal of the American Medical Association, 266, 1947–1952.

    PubMed  CAS  Google Scholar 

  • Paronis, C. A., and Holtzman, S. G. (1994). Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists. Psvchopharnracolog. 114, 601–310.

    CAS  Google Scholar 

  • Pfeiffer, A., Branti, V., Herz, A., and Emrich, H. M. (1986). Psychotomimesis mediated by opiate receptors. Science, 233, 774–776.

    PubMed  CAS  Google Scholar 

  • Pickens, R., Meisch, R. A., and Thompson, T. (1978). Drug self-administration: An analysis of the reinforcing effects of drugs. In L. L. Iversen, D. Iversen, and S. Snyder (Eds.), Handbook of psvchopharmacology (pp. 1–7 ). New York: Plenum.

    Google Scholar 

  • Picker, M. J. (1991). Discriminative stimulus properties of (+)- and (-)-n-allylnormetazocine: The role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds. Behavioural Pharnracologv, 2, 497–511.

    Google Scholar 

  • Picker, M. J. (1994). Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure. Journal of Pharmacology and Experimental Therapeutics, 268, 1 190–1 198.

    Google Scholar 

  • Picker, M. J. (1995). Assessment of the kappa agonist and antagonist properties of mixed action opioids, mu opioids, and a delta opioid in pigeons. Experimental and Clinical Psychopharmacology, 3, 240.

    CAS  Google Scholar 

  • Picker, M. J., and Dykstra, L. A. (1987). Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons. Journal of Pharmacology and Experimental Therapeutics, 243, 938–945.

    PubMed  CAS  Google Scholar 

  • Picker, M. J., and Dykstra, L. A. (1989). Discriminative stimulus effects of mu and kappa opioids in the pigeon: Analysis of the effects of full and partial mu and kappa agonists. Journal of Pharmacology and Experimental Therapeutics, 249, 557–566.

    PubMed  CAS  Google Scholar 

  • Picker, M. J., Negus, S. S., and Dykstra, L. A. (1989). Opioid-like discriminative stimulus properties of benzomorphans in the pigeon: Stereospecificity and differential substitution patterns. Life Sciences, 45, 1637–1645.

    PubMed  CAS  Google Scholar 

  • Picker, M. J., Yarbrough, J., Hughes, C. E., Smith, M. A., Morgan, D., and Dykstra, L. A. (1993). Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: Influence of training dose, intrinsic efficacy and interanimal differences. Journal of Pharmacology and Experimental Therapeutics, 266, 756–767.

    PubMed  CAS  Google Scholar 

  • Picker, M. J., Benyas, S., Horwitz, J., Thompson, K., Mathewson, C., and Smith, M. A. (1996). Discrimina-tive stimulus effects of butorphanol: Influence of training dose on the substitution patterns produced by mu, kappa, and delta opioids. Journal of Pharmacology and Experimental Therapeutics, 279, 1130–1141.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., and Bigelow, G. E. (1993). Differential naltrexone antagonism of hydromorphine and pentazocine effects in human volunteers. Journal of Pharmacology and Experimental Therapeutics, 264, 813–823.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., and Bigelow, G. E. (1994). Drug discrimination assessment of agonist—antagonist opioids in humans: a three-choice saline-hydromorphonebutorphanol procedure. Journal of Pharmacology and Experimental Therapeutics, 271, 48–60.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., and Jasinski, D. R. (1991). Abuse liability studies of opioid agonist—antagonists in humans. Drug and Alcohol Dependence, 28, 49–82.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., Bigelow, G. E., and Liebson, I. A. (1985). Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification. Clinical Pharmacology and Therapeutics, 38, 219–227.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., Bigelow, G. E., Bickel, W., and Liebson, I. A. (1987). Three-choice drug discrimination in opioiddependent humans: Hydromorphone, naloxone and saline. Journal of Pharmacology and Experimental Therapeutics, 243, 1002–1009.

    Google Scholar 

  • Preston, K. L., Bigelow, G. E., and Liebson, 1. A. (1987). Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts. Journal of Pharmacology and Experimental Therapeutics, 240, 900–910.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., Bigelow, G. E., and Liebson, I. A. (1988). Butorphanol-precipitated withdrawal in opioiddependent human volunteers. Journal of Pharmacology and Experimental Therapeutics. 246, 441–448.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., Bigelow, G. E., Bickel, W. K., and Liebson, I. A. (1989). Drug discrimination in human post-addicts: Agonist—antagonist opioids. Journal of Pharmacology and Experimental Therapeutics, 250, 184–196.

    Google Scholar 

  • Preston, K. L., Bigelow, G. E., and Liebson, I. A. (1989). Antagonist effects of nalbuphine in opioid-dependent human volunteers. Journal of Pharmacology and Experimental Therapeutics, 248, 929–937.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., Bigelow, G. E., and Liebson, I. A. (1990). Discrimination of butorphanol and nalbuphine in opioid-dependent humans. Pharmacology, Biochemistry and Behavior; 37, 511–522.

    Google Scholar 

  • Preston, K. L., Liebson, I. A., and Bigelow, G. E. (1992). Discrimination of agonist—antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination. Journal of Pharmacology and Experimental Therapeutics, 261, 62–71.

    PubMed  CAS  Google Scholar 

  • Schaefer, G. J., and Holtzman, S. G. (1977). Discriminative effects of morphine in the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics, 201, 67–75.

    PubMed  CAS  Google Scholar 

  • Schechter, N. L., Berrien, F. B., and Katz, S. M. (1988). The use of patient-controlled analgesia in adolescents with sickle cell crisis pain: A preliminary report. Journal of Pain and Symptom Management, 2, 109–113.

    Google Scholar 

  • Schuster, C. R. (1976). Drugs as reinforcers in monkey and man. Pharmacological Reviews, 27, 511–521.

    Google Scholar 

  • Schuster, C. R., Smith, B. B., and Jaffe, J. H. (1971). Drug abuse in heroin users: An experimental study of self-administration of methadone, codeine, and pentazocine. Archives of General Psychiatry, 24, 359–362.

    PubMed  CAS  Google Scholar 

  • Shannon, H., and Holtzman, S. G. (1979). Morphine training dose: A determinant of stimulus generalization to narcotic antagonists in the rat. Psvchopharnmcologu 61, 239–244.

    Google Scholar 

  • Shannon, H. E. (1983). Pharmacological evaluation of nallylnormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat. Journal of Pharmacology and Experimental Therapeutics, 225, 144–152.

    PubMed  CAS  Google Scholar 

  • Shannon, H. E., and Holtzman, S. G. (1976). Evaluation of the discriminative stimulus effects of morphine in the rat. Journal of Pharmacology and Experimental Therapeutics, 198, 54–65.

    PubMed  CAS  Google Scholar 

  • Shearman, G., and Herz, A. (1981). Discriminative stimulus properties of bremazocine in the rat. Neuropharmacology, 20, 1209–1213.

    PubMed  CAS  Google Scholar 

  • Shearman, G., and Herz, A. (1982). Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors. Journal of Pharmacology and Experimental Therapeutics, 221, 735–739.

    PubMed  CAS  Google Scholar 

  • Shippenberg, T. S., and Bals-Kubik, R. (1991). Motivational aspects of opioids: Neurochemical and neuroanatomical substrates. In O. Almedia and T. S. Shippenberg (Eds.), The neurobiology of opioids (pp. 331–350 ). New York: Springer-Verlag.

    Google Scholar 

  • Shippenberg, T. S., Bals-Kubik, R., and Herz, A. (1987). Motivational properties of opioids: Evidence that an activation of delta-receptors mediates reinforcement processes. Brain Research, 436, 234–239.

    PubMed  CAS  Google Scholar 

  • Slifer, B., and Balster, R. L. (1983). Reinforcing properties of stereoisomers of the putative sigma agonists Nallynormetazocine and cyclazocine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 225, 522–528.

    PubMed  CAS  Google Scholar 

  • Spiga, R., Grabowski, J., Silverman, P. B., and Meisch, R. A. (1996). Human methadone self-administration: Effects of dose and ratio requirement. Behavioural Pharmacology, 7, 130–137.

    Google Scholar 

  • Stitzer, M., Bigelow, G., and Liebson, I. (1979). Supplementary methadone self administration among methadone maintenance clients. Addictive Behaviors, 4, 61–66.

    PubMed  CAS  Google Scholar 

  • Stitzer, M. L., McCaul, M. E., Bigelow, G. E., and Liebson, I. A. (1983). Oral methadone self-administration: Effects of dose and alternative reinforcers. Clinical Pharmacology and Therapeutics, 34, 29–35.

    Google Scholar 

  • Strain, E. C., Preston, K. L., Liebson, I. A., and Bigelow, G. E. (1992). Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. Journal of Pharmacology and Experimental Therapeutics. 261, 985–993.

    PubMed  CAS  Google Scholar 

  • Strain, E. C., Preston, K. L., Liebson, I. A., and Bigelow, G. E. (1993). Precipitated withdrawal by pentazocine in methadone-maintained volunteers. Journal of Pharmacology and Experimental Therapeutics, 267, 624–634.

    PubMed  CAS  Google Scholar 

  • Strain, E. C., Preston, K. L., Liebson, I. A., and Bigelow, G. E. (1995). Buprenorphine effects in methadone-maintained volunteers: Effects at two hours after methadone. Journal of Pharmacology and Experimental Therapeutics, 272, 628–638.

    PubMed  CAS  Google Scholar 

  • Tang, A., and Collins, R. (1985). Behavioral effects of a novel kappa opioid analgesic, U-50,488, in rats and rhesus monkeys. Psychopharmacologu 85, 309–314.

    CAS  Google Scholar 

  • Tang, A. H., and Code, R. A. (1983). Discriminative stimulus properties of nalorphine in the rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics. 227. 563–569.

    PubMed  CAS  Google Scholar 

  • Teal, J. J., and Holtzman, S. G. (1980a). Discriminative stimulus effects of cyclazocine in the rat. Journal of Pharmacology and Experimental Therapeutics, 212, 368–376.

    PubMed  CAS  Google Scholar 

  • Teal, J. J., and Holtzman, S. G. (1980b). Stereoselectivity of the stimulus effects of morphine and cyclazocine in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 215. 369–376.

    PubMed  CAS  Google Scholar 

  • Thompson, T., and Schuster, C. R. (1964). Morphine self-administration, food-reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacologia. 5. 87–94

    Google Scholar 

  • Ukai, M., and Holtzman, S. G. (1988). Morphine-like discriminative stimulus effects of opioid peptides: Possible modulatory role of D-Ala’-D-Leu`-enkephalin (DADL) and dynorphin A(1–13). Psychopharmacologu 94, 32–37.

    CAS  Google Scholar 

  • Vanecek, S., and Young, A. (1995). Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behavioural Pharmacology, 6, 669–681.

    PubMed  CAS  Google Scholar 

  • Villarreal, J. E. (1973). The effects of morphine agonists and antagonists on morphine-dependent rhesus monkeys. In H. Kosterlitz, H. Collier, and J. Villarreal (Eds.), Agonist and antagonist actions of analgesic drugs (pp. 73–83 ). Baltimore: University Park Press.

    Google Scholar 

  • Walker, E. A., and Young, A. M. (1993). Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. Journal of Pharmacology and Experimental Therapeutics, 267, 322–330.

    PubMed  CAS  Google Scholar 

  • Walker, E. A., Makhay, M. M., House, J. D., and Young, A. M. (1994). In vivo apparent pA, analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. Journal of Pharmacology and Experimental Therapeutics, 271, 959–968.

    PubMed  CAS  Google Scholar 

  • Walsh, S. L.. June, H. L., Schuh, K. J., Preston, K. L., Bigelow, G. E., and Stitzer, M. L. (1995). Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacologu 119, 268–276.

    CAS  Google Scholar 

  • Walsh, S. L., Preston, K. L., Bigelow, G. E., and Stitzer, M. L. (1995). Acute administration of buprenorphine in humans: Partial agonist and blockade effects. Journal of Pharmacology and Experimental Therapeutics. 274, 36I - 372.

    Google Scholar 

  • White, G. H., and Holtzman, S. G. (1982). Properties of pentazocine as a discriminative stimulus in the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics, 223, 396–401.

    PubMed  CAS  Google Scholar 

  • White, J., and Holtzman, S. G. (1981). Three-choice drug discrimination in the rat: Morphine, cyclazocine and saline. Journal of Pharmacology and Experimental Therapeutics, 217, 254–262.

    PubMed  CAS  Google Scholar 

  • White, J. M., and Holtzman, S. (1983). Three-choice drug discrimination: Phencyclidine-like stimulus effects of opioids. Psychopharmacologu 80, 1–9.

    CAS  Google Scholar 

  • Winger, G., and Woods, J. H. (1996). Effects of buprenorphine on behavior maintained by heroin and alfentanil in rhesus monkeys. Behavioural Pharmacology, 7, 155–159.

    PubMed  CAS  Google Scholar 

  • Winger, G.. Skjoldager, P., and Woods. J. H. (1992). Effects of buprenorphine and other opioid agonists and antagonists on alfentanil-and cocaine-reinforced responding in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics. 26/. 311–317.

    Google Scholar 

  • Winger. G., Woods, J. H.. and Hursh, S. R. (1996). Behavior maintained by alfentanil or nalbuphine in rhesus monkeys: Fixed-ratio and time-out changes to establish demand curves and relative reinforcing effectiveness. Experimental and Clinical Psychopharmacologu 4, 131–140.

    CAS  Google Scholar 

  • Woods, J. H. (1977). Narcotic-reinforced responding: A rapid screening procedure. In Proceedings of the 39th meeting of the Committee on Problems of Drug Dependence (pp. 420–437 ). Cambridge, MA: National Academy of Sciences.

    Google Scholar 

  • Woods, J. H., and Winger, G. (1987). Behavioral characterization of opioid mixed agonist-antagonists. Drug and Alcohol Dependence, 20, 303–315.

    PubMed  CAS  Google Scholar 

  • Woods, J. H., Young, A. M., and Herling, S. (1982). Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys. Federation Proceedings, 41, 221–227.

    PubMed  CAS  Google Scholar 

  • Woods, J. H., France, C. P., and Winger, G. D. (1992). Behavioral pharmacology of buprenorphine: Issues relevant to its potential in treating drug abuse (NIDA Research Monograph Series No. 121, pp. 12–27 ). Rockville, MD: National Institute on Drug Abuse.

    Google Scholar 

  • Yanagita, T., Katoh, S., Wakasa, Y., and Oinuma, N. (1982). Drug dependence liability of pentazocine evaluated in the rhesus monkey. Central Institute Experimental Animal Preclinical Report, I, 51–57.

    Google Scholar 

  • Young, A. M. (1991). Discriminative stimulus profiles of psychoactive drugs. In N. K. Mello (Ed.), Ad-ounces in substance abuse, behavioral and biological research (Vol. 4, pp. 139–203N ). London: Kingsley.

    Google Scholar 

  • Young, A. M., and Stephens, K. (1984). Antagonism of the discriminative stimulus effects of ethylketazocine, cyclazocine, and nalorphine in macaques. Psychopharmacology, 84, 356–361.

    PubMed  CAS  Google Scholar 

  • Young, A. M., Swain, H. H., and Woods, J. H. (1981). Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys. Psychopharmacology, 74, 329–335.

    PubMed  CAS  Google Scholar 

  • Young, A. M., Stephens, K. R., Hein, D. W, and Woods, J. H. (1984). Reinforcing and discriminative stimulus properties of mixed agonists-antagonist opioids. Journal of Pharmacology and Experimental Therapeutics, 229, 118–126.

    PubMed  CAS  Google Scholar 

  • Young, A. M., Kapitsopoulos, G., and Makhay, M. (1991). Tolerance to morphine-like stimulus effects of mu opioid agonists. Journal of Pharmacology and Experimental Therapeutics, 257, 795–805.

    Google Scholar 

  • Young, A. M., Masaki, M. A., and Geula, C. (1992). Discriminative stimulus effects of morphine: Effects of training dose on agonist and antagonist effects of mu opioids. Journal of Pharmacology and Experimental Therapeutics, 261, 246–257.

    PubMed  CAS  Google Scholar 

  • Zacny, J. P., Lichtor, J. L., and de Wit, H. (1992). Subjective, behavioral, and physiologic responses to intravenous dezocine in healthy volunteers. Anesthesia and Analgesia, 74, 523–530.

    PubMed  CAS  Google Scholar 

  • Zacny, J. P., Lichtor, J. L., Zaragoza, J. G., and de Wit, H. (1992). Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology, 107, 319–326.

    PubMed  CAS  Google Scholar 

  • Zacny, J. P., Lichtor, J. L., Binstock, W, Coalson, D. W., Cutter, T., Flemming, D. C., and Glosten, B. (1993). Subjective, behavioral and physiological responses to intravenous meperidine in healthy volunteers. Psychopharmacology, 111, 306–314.

    PubMed  CAS  Google Scholar 

  • Zacny, J. P., Lichtor, J. L., Flemming, D., Coalson, D. W, and Thompson. W. K. (1994). A dose-response analysis of the subjective, psychomotor, and physiological effects of intravenous morphine in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics, 268, 1–9.

    PubMed  CAS  Google Scholar 

  • Zacny, J. P., Lichtor, J. L., Thapar, P., Coalson, D. W, Flemming, D., and Thompson, W. K. (1994). Comparing the subjective, psychomotor, and physiological effects of intravenous butorphanol and morphine in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics, 270, 579–588.

    PubMed  CAS  Google Scholar 

  • Zacny, J. P., McKay, M. A., Toledano, A. Y., Marks, S., Young, C. J., Klock, P. A., and Apfelbaum, J. L. (1996). The effects of a cold-water immersion stressor on the reinforcing and subjective effects of an opioid in healthy volunteers. Drug and Alcohol Dependence, 42, 133–142.

    PubMed  CAS  Google Scholar 

Appendix

  • Bigelow, G. E., and Preston, K. L. (1995). Opioids. In F. E. Bloom, and D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 1731–1744 ). New York: Raven.

    Google Scholar 

  • Childress. A. R., Hole, A. V, Ehrman, R. N., Robbins, S. J., McLellan, A. T., and O’ Brien, C.P. (1993). Cue reactivity and cue reactivity interventions in drug dependence (NIDA Research Monograph Series No. 137, pp. 73–95 ).

    Google Scholar 

  • Washington, DC: U.S. Government Printing Office. de Zwaan, M., and Mitchell, J. E. (1992). Opiate antagonists and eating behavior in humans: A review. Journal of Clinical Pharmacology, 32, 1060–1072.

    Google Scholar 

  • Di Chiara, G., and North, R. A. (1992). Neurobiology of opiate abuse. Trends in the Pharmacological Sciences, 13, 185–193.

    Google Scholar 

  • Dykstra, L. A. (1996). Opioid analgesics. In C. R. Schuster and M. J. Kuhar (Eds.), Pharmacological aspects of drug dependence (pp. 197–232 ). Berlin: Springer.

    Google Scholar 

  • Morley, J. E., Levine, A. S., Yim, G. K., and Lowy, M. T. (1983) Opioid modulation of appetite. Neuroscience and Biobehavioral Reviews, 7, 281–305.

    Google Scholar 

  • Olson, G. A., Olson, R. D., and Kastin, A. J. (1995). Endogenous opioids: 1994. Peptides, 16, 1517–1555. [Note: this is one of a series of articles that date back to 1979 that summarize research from a given year or years on a number of opioid effects on behavior.]

    Google Scholar 

  • Pfaus, J. G., and Gorzalka, B. B. (1987). Opioids and sexual behavior. Neuroscience and Biobehavioral Reviews, 11, 1–34.

    PubMed  CAS  Google Scholar 

  • Preston, K. L., and Jasinski, D. R. (1991). Abuse liability studies of opioid agonist-antagonists in humans. Drug and Alcohol Dependence, 28, 49–82.

    PubMed  CAS  Google Scholar 

  • Schaefer, G. J. (1992). Opiate antagonists and rewarding brain stimulation. Neuroscience and Biobehavioral Reviews, 12, 1–17.

    Google Scholar 

  • Spanagel, R. (1995). Modulation of drug-induced sensitization processes by endogenous opioid systems. Behavioural Brain Research, 70, 37–49.

    PubMed  CAS  Google Scholar 

  • Stewart, J., de Wit, H., and Eikelboom, R. (1984). Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychological Review, 91, 251–268.

    PubMed  CAS  Google Scholar 

  • Young, A. M., and Sannerud, C. A. (1989). Tolerance to drug discriminative stimuli. In A. Goudie and M. Emmett-Oglesby (Eds.), Psychoactive drugs (pp. 221–278 ). Clifton, NJ: Humana.

    Google Scholar 

  • Zacny, J. P. (1995). A review of the effects of opiates on psychomotor and cognitive functioning in humans. Experimental and Clinical Psychopharmacology. 3, 432–466.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia and Critical Care, The University of Chicago, Chicago, Illinois, 60637, USA

    James P. Zacny

  2. Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA

    Ellen A. Walker

Authors
  1. James P. Zacny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ellen A. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Ralph E. Tarter  & Peggy J. Ott  & 

  2. Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania, USA

    Robert T. Ammerman

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Zacny, J.P., Walker, E.A. (1998). Behavioral Pharmacology of Opiates. In: Tarter, R.E., Ammerman, R.T., Ott, P.J. (eds) Handbook of Substance Abuse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2913-9_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2913-9_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3297-6

  • Online ISBN: 978-1-4757-2913-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation